DK538485A - Rekombinante dna-molekyler - Google Patents

Rekombinante dna-molekyler Download PDF

Info

Publication number
DK538485A
DK538485A DK538485A DK538485A DK538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A
Authority
DK
Denmark
Prior art keywords
recombinant dna
dna molecules
molecules
recombinant
dna
Prior art date
Application number
DK538485A
Other languages
English (en)
Other versions
DK538485D0 (da
Inventor
A R Dunn
N M Gough
D Metcalf
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK538485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp filed Critical Research Corp
Publication of DK538485A publication Critical patent/DK538485A/da
Publication of DK538485D0 publication Critical patent/DK538485D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK538485A 1984-03-21 1985-11-21 Rekombinante dna-molekyler DK538485D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG417384 1984-03-21
PCT/US1985/000465 WO1985004188A1 (en) 1984-03-21 1985-03-19 Recombinant dna molecules

Publications (2)

Publication Number Publication Date
DK538485A true DK538485A (da) 1985-11-21
DK538485D0 DK538485D0 (da) 1985-11-21

Family

ID=3770545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK538485A DK538485D0 (da) 1984-03-21 1985-11-21 Rekombinante dna-molekyler

Country Status (8)

Country Link
US (1) US5602007A (da)
EP (2) EP0574029A1 (da)
JP (3) JPS61501490A (da)
AU (2) AU594014B2 (da)
DE (1) DE3587864T2 (da)
DK (1) DK538485D0 (da)
NL (1) NL940022I1 (da)
WO (1) WO1985004188A1 (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8302096A1 (es) 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
EP0337359B1 (en) * 1984-07-06 1998-10-21 Novartis AG Lymphokine production and purification
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
ES8705470A1 (es) * 1984-11-20 1987-05-01 Schering Biotech Corp Un procedimiento para producir un polipeptido
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
DE3681551D1 (de) * 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
EP0232707A1 (en) * 1986-01-09 1987-08-19 Ajinomoto Co., Inc. Human hematopoietic cell growth potentiating factor
US5106733A (en) * 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
AU615550B2 (en) * 1988-04-21 1991-10-03 Medvet Science Pty. Ltd. Human gm-csf variants
AU637133B2 (en) * 1989-08-11 1993-05-20 Amrad Operations Pty. Limited Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
ATE440957T1 (de) 1993-09-15 2009-09-15 Novartis Vaccines & Diagnostic Rekombinante alphavirus vektoren
US5777193A (en) * 1994-03-04 1998-07-07 Ludwig Institute For Cancer Research Animals with targeted gene disruption
ATE386811T1 (de) 1996-04-05 2008-03-15 Novartis Vaccines & Diagnostic Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
EP2298900A1 (en) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for treating intracellular diseases
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
DE69838552T2 (de) * 1997-07-14 2008-05-21 Bolder Biotechnology, Inc., Louisville Derivate des wachstumshormons und verwandte proteine
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
EP1019082B2 (en) 1997-10-02 2008-06-04 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections
EP1141313A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
WO2000047195A1 (en) * 1999-02-12 2000-08-17 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
JP2004506021A (ja) * 2000-08-11 2004-02-26 ファブリル　インコーポレイテッド Ｔ細胞媒介性病態を改変するための方法および組成物
US6911204B2 (en) * 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP2292772A1 (en) 2001-07-05 2011-03-09 Novartis Vaccines and Diagnostics, Inc. HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
ATE444308T1 (de) 2002-02-13 2009-10-15 Ludwig Inst Cancer Res Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
ES2627445T3 (es) 2002-05-01 2017-07-28 Miltenyi Biotec Technology, Inc. Partículas de vector de lentivirus resistentes a la inactivación por el complemento
GB0210741D0 (en) * 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0224415D0 (en) * 2002-10-21 2002-11-27 Medical Res Council Compositions
US8541003B2 (en) 2003-06-20 2013-09-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
EP2266602A3 (en) 2004-11-01 2011-08-10 Novartis Vaccines and Diagnostics, Inc. Combination approaches for generating immune responses
GB0524103D0 (en) * 2005-11-26 2006-01-04 Medical Res Council Healing
EP3181585A3 (en) 2006-02-08 2017-08-30 Morphotek, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
US20100196336A1 (en) 2006-05-23 2010-08-05 Dongsu Park Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
AU2010307075B2 (en) 2009-10-12 2014-12-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Granulysin in immunotherapy
WO2012093258A2 (en) 2011-01-05 2012-07-12 Imperial Innovations Limited Treatment and screening
WO2014008475A2 (en) 2012-07-05 2014-01-09 The Ohio State University Compositions and methods related to viral vaccines
EP3344290A4 (en) 2015-08-31 2019-02-27 Technovax, Inc. VACCINE BASED ON VIRUS-LIKE PARTICLES OF HUMAN RESPIRATORY SYNZYTIAL VIRUS (HRSV)
CA3010987A1 (en) 2016-01-08 2017-07-13 Replimune Limited Oncolytic herpes simplex virus type 1 strain
US10538786B2 (en) 2016-04-13 2020-01-21 Janssen Pharmaceuticals, Inc. Recombinant arterivirus replicon systems and uses thereof
KR20190082226A (ko) 2016-10-17 2019-07-09 신테틱 제노믹스, 인코포레이티드. 재조합 바이러스 레플리콘 시스템 및 그의 용도
BR112019011661A2 (pt) 2016-12-05 2020-01-07 Synthetic Genomics, Inc. Composições e métodos para aumentar expressão de gene
US11020476B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
EA202091517A1 (ru) 2017-12-19 2020-11-03 Янссен Сайенсиз Айрлэнд Анлимитед Компани Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
US11021692B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Hepatitis B virus (HBV) vaccines and uses thereof
WO2019143949A2 (en) 2018-01-19 2019-07-25 Synthetic Genomics, Inc. Induce and enhance immune responses using recombinant replicon systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (da) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4658018A (en) * 1984-03-13 1987-04-14 Immunex Corporation Process for producing homogeneous colony stimulating factor
EP0337359B1 (en) * 1984-07-06 1998-10-21 Novartis AG Lymphokine production and purification
ES8705470A1 (es) * 1984-11-20 1987-05-01 Schering Biotech Corp Un procedimiento para producir un polipeptido
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use

Also Published As

Publication number Publication date
EP0574029A1 (en) 1993-12-15
JPH10165190A (ja) 1998-06-23
AU5589390A (en) 1990-09-13
NL940022I1 (nl) 1995-01-02
DE3587864D1 (de) 1994-07-28
JPS61501490A (ja) 1986-07-24
EP0177568B1 (en) 1994-06-22
EP0177568A1 (en) 1986-04-16
AU629938B2 (en) 1992-10-15
AU594014B2 (en) 1990-03-01
WO1985004188A1 (en) 1985-09-26
EP0177568A4 (en) 1987-10-08
AU4008485A (en) 1985-09-26
JPH09271A (ja) 1997-01-07
US5602007A (en) 1997-02-11
DK538485D0 (da) 1985-11-21
DE3587864T2 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
NL940022I1 (nl) Recombinant-dna-moleculen
DK467385D0 (da) Dna-fragmenter
DK552285A (da) Proteinkonjugat
DK112586D0 (da) Virus-dna
DK180486D0 (da) Varmeapparat
DK224886D0 (da) Proteinbestemmelse
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
GB8404378D0 (en) Dna sequence recombinant dna molecules
DK600586D0 (da) Protein
NO170503C (no) Broennhull-proevetaker
BR8600164A (pt) Coluna de fracionamento
DK395385D0 (da) Varmeapparat
FI852866L (fi) Rekombinantfaktor viii-r.
DE3582362D1 (de) Elektrophoretisches element.
DK319888A (da) Dna-fragmenter
GB8406569D0 (en) Recombinant dna molecules
GB8319265D0 (en) Recombinant dna molecules
NO850732L (no) Rekombinante dna-molekyler
DK51585D0 (da) Proteinkoncentrater
DK161609C (da) Elektroforeseanordning
GB8619300D0 (en) Recombinant dna molecules
ES278395Y (es) Pipeta mejorada
DK286D0 (da) Elektroforeseapparat
GB8405655D0 (en) Molecules by electrophoresis
SE8505275D0 (sv) Armering

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment